News

BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017

BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2017 earnings on Tuesday, August 8 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, August 8, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.

Jul 31, 2017

BioTelemetry, Inc. Completes LifeWatch AG Acquisition

BioTelemetry, Inc. (NASDAQ:BEAT), announced today it has completed its acquisition of LifeWatch AG (SIX:LIFE). “We are gratified that LifeWatch AG shareholders embraced the immense strategic value and potential of this acquisition and moved quickly to support the BioTelemetry tender,” said Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc.

Jul 12, 2017

BioTelemetry, Inc. Reaches a Final Milestone in Acquisition of LifeWatch AG

BioTelemetry, Inc. (NASDAQ:BEAT), announced today the definitive results of the tender offer for LifeWatch AG (SIX:LIFE) which concluded on June 28, 2017. The definitive results show shareholders have tendered 17,848,661 shares of LifeWatch, representing approximately 97% of the total shares outstanding.

Jul 7, 2017

BioTelemetry, Inc. Reaches Key Milestone in Tender Offer for LifeWatch AG

BioTelemetry, Inc. (NASDAQ:BEAT), announced today that during the main offer period which ended on June 8, 2017, the preliminary results show shareholders have tendered 15,161,925 shares of LifeWatch AG (SIX:LIFE), representing approximately 82% of the total shares outstanding.

Jun 9, 2017

BioTelemetry, Inc. Announces Extension of the Tender Offer Period for LifeWatch AG Shares

BioTelemetry, Inc. (NASDAQ:BEAT), announced today that, in accordance with the provisions of the Offer Prospectus and at the Company’s request, the Swiss Takeover Board has extended the initial main offer period of the tender offer to acquire all of the shares of LifeWatch AG (SIX:LIFE), which was scheduled to expire at 4:00 p.m. CEST, on […]

May 23, 2017

BioTelemetry, Inc. Reports First Quarter 2017 Financial Results

BioTelemetry, Inc. (NASDAQ:BEAT), today reported results for the first quarter ended March 31, 2017. Company Highlights include: Recognized highest quarterly revenue in Company’s history of $55.9 million, a 14.9% increase over the prior year. Achieved 19th consecutive quarter of year over year revenue growth. Serviced the highest quarterly patient volume in the Company’s history. Recorded […]

May 3, 2017

BioTelemetry, Inc. to Release First Quarter 2017 Earnings Results on May 3, 2017

BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2017 earnings on Wednesday, May 3, 2017 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 3, 2017. The broadcast will be available through the investor information section of the BioTelemetry website at www.gobio.com.

Apr 25, 2017

BioTelemetry, Inc. to Hold Investor Call on April 10, 2017

BioTelemetry, Inc. (NASDAQ:BEAT) will hold an investor call tomorrow, April 10, 2017 at 9:00am EDT to discuss the recently announced transaction agreement for BioTelemetry to launch a tender offer to acquire LifeWatch AG. The broadcast will be available through the investor information section of the BioTelemetry website: www.gobio.com. If you are unable to participate during […]

Apr 10, 2017

BioTelemetry, Inc. Launches a Tender Offer to Acquire LifeWatch AG

BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that the companies have entered into a definitive transaction agreement under which BioTelemetry will launch a tender offer in Switzerland to acquire all of the outstanding shares of LifeWatch AG.

Apr 9, 2017

BioTelemetry, Inc. to Release Fourth Quarter 2016 Earnings Results on February 22, 2017

BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2016 earnings on Wednesday, February 22, 2017 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 22, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.

Feb 13, 2017

Sprint & BioTelemetry, Inc. Receive a 2017 IoT Evolution Business Impact Award

Sprint (NYSE:S) announced today that a 2017 IoT Evolution Business Impact Award will be presented to Sprint and its client, BioTelemetry, Inc., by TMC and Crossfire Media at the IoT Evolution Conference & Expo on February 9, 2017. Sprint and BioTelemetry will present the winning case at the Expo.

Feb 6, 2017

BioTelemetry, Inc. Announces Acquisition of Telcare’s Remote Diabetes Management Platform

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce the acquisition of Telcare Medical Supply, Inc. and associated assets (“Telcare”), increasing the Company’s presence in the large and rapidly growing digital population health management […]

Dec 1, 2016

BioTelemetry, Inc. Reports Third Quarter 2016 Financial Results

BioTelemetry, Inc. (NASDAQ:BEAT), today reported results for the third quarter ended September 30, 2016. Company Highlights include: Recognized highest quarterly revenue in Company’s history of $53.1 million, a 22% increase over the prior year. Recorded $4.1 million GAAP net income for the third quarter. Realized highest quarterly adjusted EBITDA in Company’s history of $12.2 million, […]

Nov 2, 2016

BioTelemetry, Inc. to Release Third Quarter 2016 Earnings Results on November 2, 2016

BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2016 earnings on Wednesday, November 2, 2016 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, November 2, 2016. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.

Oct 24, 2016

BioTelemetry, Inc. Announces CE Mark Approval of Holter Analysis Software

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that the Company has received CE mark approval of its Holter analysis software.

Aug 29, 2016

BioTelemetry, Inc. Reports Second Quarter 2016 Financial Results

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2016.

Aug 2, 2016

BioTelemetry, Inc. to Release Second Quarter 2016 Earnings Results on August 2, 2016

BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2016 earnings on Tuesday, August 2, 2016 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, August 2, 2016. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.

Jul 26, 2016

BioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT™ Patch

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that it has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance of its next generation Mobile Cardiac Outpatient Telemetry™ device, the MCOT™ Patch.

Jul 26, 2016

BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions.

May 11, 2016

BioTelemetry, Inc. Reports First Quarter 2016 Financial Results

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2016.

Apr 26, 2016

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.

ioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, announced today that the two companies have entered into a definitive agreement whereby BioTelemetry will acquire VirtualScopics.

Mar 25, 2016

Events

Mobile in Clinical Trials Summit

Boston, MA

Join us to discover how mobile apps, platforms and devices provide endless possibilities and opportunities for patients and clinical trials.

Sep 6-6, 2017

OCT New England

Boston, MA - Booth #72

Join BioTelemetry Research experts to learn how to better manage vendor contracts and overcome challenges you may face during your clinical trial.

Sep 6-7, 2017

Outsourcing in Clinical Trials: Midwest

Chicago, IL

BioTelemetry Research experts will be present and available to discuss your clinical trial needs. This unique event brings together leading pharma, device and biotech professionals from across the Midwest region.

Sep 12-13, 2017

OCT Southern California

San Diego, CA - Booth #41

Join BioTelemetry Research experts, for two days of constructive networking and in-depth presentations on the latest challenges and developments facing the clinical operations and outsourcing community in Southern California.

Sep 27-28, 2017

OCT Canada – Toronto

Toronto, Canada

Discover how to maximize the value and efficiency of outsourcing strategies, by sharing experiences and strengthening your network by meeting with BioTelemetry Research experts.

Oct 18-19, 2017

CSRC Annual Meeting

Washington, D.C.

Join BioTelemetry Research experts as they meet with industry leaders to discuss the assessment and risk mitigation of cardiac safety signals in oncology drug development.

Oct 24-25, 2017

OCT Pacific Northwest

Seattle, WA

Join BioTelemetry Research experts in Seattle to discuss the latest challenges and developments facing the clinical operations and outsourcing community in the region.

Oct 25-26, 2017